Add BrightSurf on Google Email

University of Texas Health Science Center at Houston


Rapamycin lotion reduces facial tumors caused by tuberous sclerosis, UTHealth reports

A new cream containing rapamycin has been shown to significantly reduce disfiguring facial tumors in people with tuberous sclerosis complex, with 80% of patients experiencing a significant improvement. The treatment offers hope for individuals affected by the condition, which affects over 50,000 people in the US.

Pioneering paper shows infection control and prevention in clinics is in everyone's hands

A pioneering paper provides a practical guide for infection control in clinics, emphasizing the importance of hand hygiene, injection safety, cleaning, sterilization, and high-level disinfection. The guide promotes a proactive approach to infection prevention and control, empowering patients to hold healthcare providers accountable.

SourceUniversity of Texas Health Science Center at Houston·JournalOpen Forum Infectious Diseases·DateMay 2, 2018

UTHealth leads ACSM paper on safety recommendations for energy drinks

The American College of Sports Medicine (ACSM) has published new safety recommendations for energy drink consumption, particularly among children, adolescents, and individuals with cardiovascular conditions. The guidelines warn against excessive caffeine intake and advise against using energy drinks before or after strenuous exercise.

SourceUniversity of Texas Health Science Center at Houston·JournalCurrent Sports Medicine Reports·DateFeb 8, 2018

Study outlines 'perfect storm' that led to Colombia's antibiotic resistance epidemic

A study by UTHealth researchers found that a 'promiscuous' carbapenemase gene and a bacterial clone carrying an antibiotic-killing gene created the perfect storm for Colombia's antibiotic resistance epidemic. The gene spread horizontally across Gram-negative bacteria, while the clone was introduced via an infected patient from the US.

SourceUniversity of Texas Health Science Center at Houston·JournalThe Journal of Infectious Diseases·DateNov 7, 2017

Gene mutation linked to retinitis pigmentosa in Southwestern US Hispanic families

A study has identified a common gene mutation linked to retinitis pigmentosa in Hispanic families from the Southwestern US, with over 70 genes now known to cause the disease. The researchers found that a dominant mutation in the arrestin-1 gene is responsible for 36% of cases, offering hope for future treatments and therapies.

SourceUniversity of Texas Health Science Center at Houston·JournalInvestigative Ophthalmology & Visual Science·DateJun 26, 2017

UTHealth researchers identify genes in children linked to stress, bipolar disorder

A recent study by UTHealth researchers has identified genetic alterations in children at high risk for bipolar disorder, which can be modulated by stress. The findings suggest that these genetic markers may contribute to the increased risk of developing bipolar disorder in children chronically exposed to stressors.

SourceUniversity of Texas Health Science Center at Houston·JournalTranslational Psychiatry·DateMay 8, 2017

UTHealth School of Public Health researchers find cold weather linked to mortality risks in Texas

Researchers at UTHealth School of Public Health found that cold temperatures significantly increase mortality risk in Texas, with a 5% increase in deaths per degree Celsius drop in winter. The study focused on 12 metropolitan areas and found that people with pre-existing heart and respiratory diseases are most vulnerable to cold weather.

SourceUniversity of Texas Health Science Center at Houston·JournalEnvironmental Pollution·DateApr 25, 2017

UTHealth awarded $1.5 million to increase HPV vaccinations in medically underserved areas

Researchers at UTHealth aim to increase HPV vaccination rates among minority youth in medically underserved areas by launching a three-year project. The initiative includes a parent-focused social marketing campaign and comprehensive school-based vaccination clinics to educate parents and adolescents about the vaccine's importance.

UTHealth receives $2.4 million grant to drive action-oriented research on healthier cities

The University of Texas Health Science Center at Houston has received a $2.4 million grant to create the Healthy Cities Research Hub, exploring drivers of diabetes and other chronic diseases in urban settings. The hub will facilitate knowledge exchange and evaluate community-based interventions aimed at improving public health in cities.

UTHealth study: 78 percent of hospital workers in Houston are overweight or obese

A recent UTHealth study found that 78 percent of hospital employees in Houston are overweight or obese. Despite a generally low intake of fruits and vegetables, participants showed significant differences in daily consumption patterns between normal weight, overweight, and obese groups.

SourceUniversity of Texas Health Science Center at Houston·JournalJournal of Occupational and Environmental Medicine·DateJan 30, 2017

UTHealth study outlines framework for identifying disease risk in genome sequence

Researchers at UTHealth have developed a framework to analyze genome sequences and identify genetic variations that raise or lower disease risk. The study used genomic data from over 3,000 individuals and identified genes related to blood lipid levels, white blood cell count, and heart attack diagnosis.

SourceUniversity of Texas Health Science Center at Houston·JournalAmerican Journal of Human Genetics·DateJan 12, 2017

UTHealth's Wolinsky is senior author of paper on new therapy for primary MS

Researchers have made significant strides in treating primary progressive multiple sclerosis (PPMS) with ocrelizumab, a medication that targets immune cells contributing to the disease. The study, led by UTHealth's Jerry Wolinsky, shows substantial improvement in slowing disability progression and reducing new lesion formation.

SourceUniversity of Texas Health Science Center at Houston·JournalNew England Journal of Medicine·DateDec 21, 2016